Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 5
1998 1
1999 1
2000 1
2001 2
2002 1
2003 1
2004 2
2006 6
2007 2
2008 4
2009 4
2010 8
2011 4
2012 9
2013 1
2014 7
2015 7
2016 5
2017 6
2018 5
2019 6
2020 11
2021 14
2022 6
2023 10
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Results by year

Filters applied: . Clear all
Page 1
A new molecular classification to drive precision treatment strategies in primary Sjögren's syndrome.
Soret P, Le Dantec C, Desvaux E, Foulquier N, Chassagnol B, Hubert S, Jamin C, Barturen G, Desachy G, Devauchelle-Pensec V, Boudjeniba C, Cornec D, Saraux A, Jousse-Joulin S, Barbarroja N, Rodríguez-Pintó I, De Langhe E, Beretta L, Chizzolini C, Kovács L, Witte T; PRECISESADS Clinical Consortium; PRECISESADS Flow Cytometry Consortium; Bettacchioli E, Buttgereit A, Makowska Z, Lesche R, Borghi MO, Martin J, Courtade-Gaiani S, Xuereb L, Guedj M, Moingeon P, Alarcón-Riquelme ME, Laigle L, Pers JO. Soret P, et al. Nat Commun. 2021 Jun 10;12(1):3523. doi: 10.1038/s41467-021-23472-7. Nat Commun. 2021. PMID: 34112769 Free PMC article.
Immunotherapy in antiphospholipid syndrome.
Lopez-Pedrera Ch, Aguirre MA, Ruiz-Limon P, Pérez-Sánchez C, Jimenez-Gomez Y, Barbarroja N, Cuadrado MJ. Lopez-Pedrera Ch, et al. Int Immunopharmacol. 2015 Aug;27(2):200-8. doi: 10.1016/j.intimp.2015.06.006. Epub 2015 Jun 15. Int Immunopharmacol. 2015. PMID: 26086363 Review.
Preclinical Characterization of Pharmacologic NAD+ Boosting as a Promising Therapeutic Approach in Rheumatoid Arthritis.
Perez-Sanchez C, Escudero-Contreras A, Cerdó T, Sánchez-Mendoza LM, Llamas-Urbano A, la Rosa IA, Pérez-Rodriguez M, Muñoz-Barrera L, Del Carmen Abalos-Aguilera M, Barbarroja N, Calvo J, Ortega-Castro R, Ruiz-Vilchez D, Moreno JA, Burón MI, González-Reyes JA, Collantes-Estevez E, Lopez-Pedrera C, Villalba JM. Perez-Sanchez C, et al. Among authors: lopez pedrera c. Arthritis Rheumatol. 2023 Oct;75(10):1749-1761. doi: 10.1002/art.42528. Epub 2023 Jul 28. Arthritis Rheumatol. 2023. PMID: 37094367
Catastrophic antiphospholipid syndrome (CAPS).
Sciascia S, Lopez-Pedrera C, Roccatello D, Cuadrado MJ. Sciascia S, et al. Among authors: lopez pedrera c. Best Pract Res Clin Rheumatol. 2012 Aug;26(4):535-41. doi: 10.1016/j.berh.2012.07.005. Best Pract Res Clin Rheumatol. 2012. PMID: 23040365 Free article. Review.
New advances in genomics and epigenetics in antiphospholipid syndrome.
López-Pedrera C, Cerdó T, Jury EC, Muñoz-Barrera L, Escudero-Contreras A, Aguirre MA, Pérez-Sánchez C. López-Pedrera C, et al. Rheumatology (Oxford). 2024 Feb 6;63(SI):SI14-SI23. doi: 10.1093/rheumatology/kead575. Rheumatology (Oxford). 2024. PMID: 38320594 Free PMC article. Review.
Antiphospholipid syndrome.
Cuadrado MJ, Lopez-Pedrera C. Cuadrado MJ, et al. Among authors: lopez pedrera c. Clin Exp Med. 2003 Nov;3(3):129-39. doi: 10.1007/s10238-003-0016-x. Clin Exp Med. 2003. PMID: 14648227 Review.
Decoding clinical and molecular pathways of liver dysfunction in Psoriatic Arthritis: Impact of cumulative methotrexate doses.
Ruiz-Ponce M, Cuesta-López L, López-Montilla MD, Pérez-Sánchez C, Ortiz-Buitrago P, Barranco A, Gahete MD, Herman-Sánchez N, Lucendo AJ, Navarro P, López-Pedrera C, Escudero-Contreras A, Collantes-Estévez E, López-Medina C, Arias-de la Rosa I, Barbarroja N. Ruiz-Ponce M, et al. Among authors: lopez pedrera c. Biomed Pharmacother. 2023 Dec;168:115779. doi: 10.1016/j.biopha.2023.115779. Epub 2023 Oct 30. Biomed Pharmacother. 2023. PMID: 37913737 Free article.
Characterization of the inflammatory proteome of synovial fluid from patients with psoriatic arthritis: Potential treatment targets.
Barbarroja N, López-Montilla MD, Cuesta-López L, Pérez-Sánchez C, Ruiz-Ponce M, López-Medina C, Ladehesa-Pineda ML, López-Pedrera C, Escudero-Contreras A, Collantes-Estévez E, Arias-de la Rosa I. Barbarroja N, et al. Among authors: lopez pedrera c. Front Immunol. 2023 Mar 22;14:1133435. doi: 10.3389/fimmu.2023.1133435. eCollection 2023. Front Immunol. 2023. PMID: 37033920 Free PMC article.
124 results